PPARγ-Mediated Increase in Glucose Availability Sustains Chronic Brucella abortus Infection in Alternatively Activated Macrophages  by Xavier, Mariana N. et al.
Cell Host & Microbe
ArticlePPARg-Mediated Increase in Glucose Availability
Sustains Chronic Brucella abortus Infection
in Alternatively Activated Macrophages
Mariana N. Xavier,1,4 Maria G. Winter,1,6 Alanna M. Spees,1,6 Andreas B. den Hartigh,1 Kim Nguyen,1 Christelle M. Roux,1
Teane M.A. Silva,4 Vidya L. Atluri,1 Tobias Kerrinnes,1 A. Marijke Keestra,1 Denise M. Monack,5 Paul A. Luciw,2
Richard A. Eigenheer,3 Andreas J. Ba¨umler,1 Renato L. Santos,4 and Rene´e M. Tsolis1,*
1Department of Medical Microbiology and Immunology, School of Medicine
2Center for Comparative Medicine
3Proteomics Core Facility, UC Davis Genome Center
University of California, Davis, Davis, CA 95616, USA
4Departamento de Clinica e Cirurgia Veterinarias, Escola de Veterinaria, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte,
MG, Brazil
5Department of Microbiology and Immunology, School of Medicine, Stanford University, Palo Alto, CA 94305, USA
6These authors contributed equally to this work
*Correspondence: rmtsolis@ucdavis.edu
http://dx.doi.org/10.1016/j.chom.2013.07.009SUMMARY
Eradication of persistent intracellular bacterial path-
ogens with antibiotic therapy is often slow or incom-
plete. However, strategies to augment antibiotics
are hampered by our poor understanding of the
nutritional environment that sustains chronic infec-
tion. Here we show that the intracellular pathogen
Brucella abortus survives and replicates prefer-
entially in alternatively activated macrophages
(AAMs), which are more abundant during chronic
infection. A metabolic shift induced by peroxisome
proliferator-activated receptor g (PPARg), which in-
creases intracellular glucose availability, is identified
as a causal mechanism promoting enhanced bacte-
rial survival in AAMs. Glucose uptake was crucial
for increased replication of B. abortus in AAMs, and
for chronic infection, as inactivation of the bacterial
glucose transporter gluP reduced both intracellular
survival in AAMs and persistence in mice. Thus, a
shift in intracellular nutrient availability induced by
PPARg promotes chronic persistence of B. abortus
within AAMs, and targeting this pathway may aid in
eradicating chronic infection.
INTRODUCTION
Brucella abortus is a zoonotic bacterial pathogen that estab-
lishes long-term infections in its host. In vivo, bacteria are found
in association with phagocytic cells, most prominently macro-
phages, in which a subset of B. abortus is able to evade killing
in phagolysosomes. Instead, bacteria replicate with an endo-
plasmic reticulum-associated compartment and interact sub-
sequently with a modified autophagy pathway to promote
cell-to-cell spread (Gorvel and Moreno, 2002; Starr et al.,Cell Hos2008). While studies on the interaction between B. abortus and
macrophages have yielded critical insights into how B. abortus
survives intracellularly, a subset of factors required for chronic
persistence in vivo do not appear tomediate intracellular replica-
tion in cultured macrophages (Fretin et al., 2005; Hong et al.,
2000), raising the possibility that the niche for chronic bacterial
persistence has different characteristics from macrophages
cultured in vitro.
Recently, it has been recognized that like other immune cells,
macrophages can adopt different functional states that are influ-
enced by the immune microenvironment (reviewed by Gordon
and Martinez, 2010; Van Dyken and Locksley, 2013). Activation
by interferon gamma (IFNg) leads to the classically activated
macrophage (CAM) phenotype, characterized by production of
nitric oxide (NO) and inflammatory cytokines such as tumor
necrosis factor alpha (TNF-a) and interleukin-6 (IL-6). During
inflammation, these cells can arise from Ly6Chigh inflammatory
monocytes that leave the bone marrow in a CCR2-dependent
manner (Shi and Pamer, 2011). In contrast, the Th2 cytokines
interleukin-4 (IL-4) and IL-13 activate signal transducer and acti-
vator of transcription 6 (STAT6) to promote development of alter-
natively activated macrophages (AAMs), which play important
roles in allergic inflammation, helminth infection, and tissue
repair (Lawrence and Natoli, 2011; Reyes and Terrazas, 2007;
Shirey et al., 2008). These macrophages express low levels of
the inflammatory monocyte marker LY6C.
In addition to roles in inflammation and immunity, CAMs and
AAMs play important roles in host physiology and metabolism
(reviewed by Chawla, 2010). Development of the AAM pheno-
type is dependent on peroxisome proliferator-activated recep-
tors (PPARs; Odegaard et al., 2007), which act downstream of
STAT6 signaling to regulate macrophage metabolism. Interest-
ingly, our previous results (Hong et al., 2000) implicated bacterial
metabolism as key to chronic B. abortus infection. Therefore, we
sought to investigate the relative importance of AAMs and CAMs
as niches for persistent infection, and to determine whether the
different metabolic programming of these two macrophage
populations contributes to chronic infection by B. abortus.t & Microbe 14, 159–170, August 14, 2013 ª2013 Elsevier Inc. 159
Figure 1. Alternatively Activated Macrophages Are More Abundant during Chronic Brucellosis
(A) B. abortus 2308 CFU counts in spleens from C57BL/6J mice (n = 5) at 3, 9, 15, 21, 30, 45, and 60 days postinfection (dpi).
(B) Numbers of macrophages (CD3B220NK1.1Ly6GCD11b+F4/80+) determined by flow cytometry in spleens of B. abortus-infected mice (n = 4) at 0, 9,
and 30 dpi.
(C) Frequency of CD3B220NK1.1Ly6GCD11b+F4/80+Ly6Chigh macrophages (CAM) measured by flow cytometry in spleens of B. abortus-infected mice
(n = 4) at 9 and 30 dpi.
(D) Frequency of CD3B220NK1.1Ly6GCD11b+F4/80+Ly6Clow macrophages determined by flow cytometry in spleens of B. abortus-infected mice (n = 4) at
9 and 30 dpi.
(E) Representative data plot of Ly6Clow and Ly6Chigh populations in spleens of B. abortus-infected mice at 9 and 30 dpi. FSC, forward scatter.
(F) Frequency of CD3B220NK1.1Ly6GCD11b+F4/80+Ly6ClowCD301+ macrophages (AAM) measured by flow cytometry in spleens of B. abortus-infected
mice (n = 4) at 9 and 30 dpi. Values represent mean ± SEM. *p < 0.05 and **p < 0.01 using one way ANOVA for (A) and (B) or unpaired t test analysis for (C)–(E). See
also Figure S1.
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Alternatively Activated Macrophages Are More
Abundant duringChronicB. abortus InfectionCompared
to Acute Infection
To gain insight into the role of different macrophage populations
during different phases of B. abortus infection, we performed an
infection time course experiment. These results showed that
early (1–3 day) bacterial numbers increased, then subsequently
declined over the next 21 days, and we designated this as the
acute phase of infection. Between 30 and 60 days postinfection,
bacterial numbers remained constant, and this was designated
the chronic infection phase (Figure 1A). During the acute phase
of infection, a short-lived Th1 response (Fernandes et al., 1996)
and an influx of inflammatory macrophages (Copin et al., 2012)
act to control bacterial colonization. However, while B. abortus
is found within CAMs early during infection, the intracellular160 Cell Host & Microbe 14, 159–170, August 14, 2013 ª2013 Elseviniche for B. abortus during the persistence phase is unknown.
To shed light on this question, we compared expression of
markers of AAMs (Figure 1 and see Figure S1 online) and
CAMs (Figure S1) in the spleen, a site of systemic B. abortus
persistence, during acute and chronic infection. While markers
of classical macrophage activation, such as Nos2 (encoding
inducible nitric oxide synthase), Il6 (encoding interleukin-6),
and Tnfa (encoding tumor necrosis factor alpha), were elevated
in splenic macrophages (CD11b+ cells) during the acute phase
of infection, expression of these markers declined during persis-
tent infection (Figure S1A). Further, while the total number of
macrophages in the spleen was increased in both acute and
chronic infection compared to uninfected mice (Figure 1B), a
significantly greater proportion of these macrophages had an in-
flammatory phenotype during acute infection, as evidenced by
their Ly6Chigh phenotype (Figures 1C and 1E), and low expres-
sion of AAM markers Ym1 and Fizz1 (Figures S1B and S1C).er Inc.
Figure 2. Increased B. abortus Survival in AAMs during Chronic Infection
(A) B. abortus survival over time in C57BL/6J BMDMs that were not treated (black diamond), or were stimulated with 10 ng/mL of rIFNg (CAM, open square) and
stimulated with 10 ng/mL of rIL-4 (AAM, gray triangle). Data shown are compiled from four independent experiments.
(B) B. abortus 2308 CFU counts in CD11b and CD11b+ splenocytes from C57BL/6J mice (n = 5) at 9 and 30 days postinfection (dpi).
(C) Frequency of B. abortus-infected CD11b+ dendritic cells (DCs, F4/80Ly6GCD11b+CD11c+), Ly6Chigh macrophages (CD11cLy6GCD11b+F4/80+
Ly6Chigh), and Ly6Clowmacrophages (CD11cLy6GCD11b+F4/80+Ly6Clow) determined by flow cytometry in CD11b+ splenocytes from infected C57BL/6Jmice
(n = 5) at 9 and 30 dpi.
(D) Representative data plot of populations shown in (C). FSC, forward scatter.
(E) Frequency of B. abortus-infected CD301+ (AAM) and CD301 Ly6Clow macrophages in CD11b+ splenocytes determined by flow cytometry in CD11b+
splenocytes fromC57BL/6J infectedmice (n = 5) at 30 dpi. Values represent mean ± SEM. *p < 0.05 and **p < 0.01 using one-way ANOVA for (A) or unpaired t test
analysis for (B), (C), and (E).
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PPARg Promotes Brucella Persistence in AAMsLy6Chigh monocytes contributed to control of B. abortus infec-
tion during the acute phase, sincemice deficient for the C-C che-
mokine receptor 2 (Ccr2/mice), which are deficient for egress
of Ly6Chigh monocytes from the bone marrow, were colonized
3-fold more highly during the acute phase (9 days) of infection
(Figure S1D). Macrophages from B. abortus-infected Ccr2/
mice also had reduced levels of inflammatory markers and
increased expression of AAM markers (Figure S1E), suggesting
that increased numbers of AAMs in the Ccr2/ mice may
contribute to the increased B. abortus colonization observed in
these mice.
In contrast to acute B. abortus infection, during the chronic
infection phase (30 days), flow cytometric analysis of splenic
macrophages (CD3B220NK1.1Ly6GCD11b+F4/80+ cells)
revealed an increase in cells with a Ly6Clow phenotype that
were positive for the AAM marker CD301 (Figures 1D–1F). In
addition, higher expression levels of the AAM markers Ym1
and Fizz1 (encoding proteins secreted by AAMs) were observed,
suggesting an increased abundance of AAMs at this time pointCell Hos(Figure S1B). Immunohistochemical analysis of Ym1 and Fizz1
expression in splenic tissue confirmed that while these AAM
markers were expressed at low levels in uninfected and acutely
infected spleen tissue, the abundance of both markers was
elevated during chronic infection, at day 30 (Figure S1C).
Together these lines of evidence provided support for the idea
that AAMs are more abundant in the spleen during the chronic
infection phase of brucellosis, and suggested that AAMs may
provide a niche for persistence of B. abortus.
AAMs Support Increased Levels of Intracellular
B. abortus Replication
To determine whether AAMs could be a preferred niche for
B. abortus, we quantified bacterial survival and replication in
bone marrow-derived macrophages (BMDMs) that were unsti-
mulated, treated with IFNg to produce CAMs, or treated with
interleukin-4 (IL-4) to produce AAMs (Figure 2A). As expected,
BMDM responded to IL-4 with increased expression of Ym1,
Fizz1, and Il6, while CAMs expressed higher levels of Il6 thant & Microbe 14, 159–170, August 14, 2013 ª2013 Elsevier Inc. 161
Figure 3. Defects in Generation of CAMs or AAMs Affect B. abortus Survival In Vivo
(A) B. abortus 2308 CFU counts in spleens from C57BL/6J and congenic Ifng/ mice (n = 5) at 3, 9, and 21 days postinfection (dpi).
(B) Frequency of CD3B220NK1.1Ly6GCD11b+F4/80+Ly6ClowCD301+ macrophages (AAM) measured by flow cytometry in spleens of B. abortus-infected
C57BL/6J and congenic Ifng/ mice (n = 5) at 9 dpi.
(C) Representative data plot of populations shown in (B).
(D) B. abortus 2308 CFU counts in spleens of C57BL/6J and congenic Stat6/ mice (n = 5) at 30 dpi.
(E) Real-time RT-PCR gene expression analysis of CAM geneNos2 and AAM gene Ym1 in CD11b+ splenocytes fromB. abortus-infected C57BL/6J and congenic
Stat6/ mice (n = 5) at 30 dpi. Values represent mean ± SEM. *p < 0.05 using unpaired t test statistical analysis. See also Figure S2.
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PPARg Promotes Brucella Persistence in AAMsAAMs (data not shown). While the CAMs eliminated intracellular
B. abortus infection, both unstimulated BMDM and AAMs were
permissive for intracellular replication of B. abortus (Figure 2A).
Remarkably, B. abortus replicated to 10-fold higher numbers in
AAMs than in untreated control BMDMs, demonstrating an
increased capacity of these cells to support intracellular infection
(Figure 2A).
To determine whether the AAMs also serve as a preferential
niche for B. abortus during chronic infection, we determined
the intracellular localization of B. abortus by enrichment of
CD11b+ cells and flow cytometry (Figure 2). During the acute
infection, B. abortus was recovered from both the CD11b+ and
the CD11b cell fraction, consistent with a previous report
(Copin et al., 2012). However, during chronic infection,
B. abortus localized predominantly to the CD11b+ fraction (Fig-
ure 2B). Flow cytometric analysis of the CD11b+ fraction
revealed that that during acute infection B. abortus localized to
CD11b+ dendritic cells, as well as to macrophages that were
Ly6Chigh and Ly6Clow (Figures 2C and 2D). In contrast, during
chronic infection, B. abortus colocalized with macrophages162 Cell Host & Microbe 14, 159–170, August 14, 2013 ª2013 Elsevithat were Ly6Clow. Since AAMs are described to express low
levels of Ly6C as well as the marker CD301, we further analyzed
the Ly6Clow population for expression of CD301 and found
an approximately 5-fold higher association of B. abortus
with Ly6Clow CD301+ cells (AAMs) than with Ly6Clow CD301
cells (Figure 2E). Together, these results demonstrated that
B. abortus preferentially associated with AAMs during chronic
(but not acute) infection.
Since the results shown above suggested that AAMs could be
a niche for intracellular persistence of B. abortus, we tested
whether mice with defects in generation of CAMs (Ifng/
mice) or AAMs (Stat6/ mice) would be altered in their ability
to control B. abortus infection (Figure 3). Consistent with findings
of other groups, Ifng/mice were severely deficient in control of
B. abortus infection during the acute phase, where bacterial
numbers increased rapidly (Figure 3A). This increased load of
B. abortus correlated with an increase in the number of Ly6Clow
CD301+ AAMs (Figures 3B and 3C). Compared to control
(C57BL/6) mice, Ifng/ mice expressed lower levels of the
CAM markers Il6 and Nos2 and higher levels of the AAM markerer Inc.
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PPARg Promotes Brucella Persistence in AAMsYm1 in splenic macrophages during the acute infection phase
(Figure S2D). Moreover, immunohistochemical analysis
confirmed increased levels of the AAM markers Ym1 and Fizz1
in spleens of Ifng/ mice during acute infection (days 9
and 21) when compared to control mice (Figure S2E, data not
shown). These results suggested that IFNg deficiency resulted
in an increase in numbers of AAMs during the acute phase of
B. abortus infection. Thus, one important role of IFNg in control-
ling B. abortus during the acute phase of infection may be to
direct the differentiation of CAMs. The opposite effect was
seen in Stat6/ mice, which demonstrated an increased ability
to control B. abortus persistence during the chronic infection
phase (30 dpi; Figure 3D). Increased control of B. abortus in
these mice correlated with decreased expression of AAM
markers and increased CAM marker expression in splenic mac-
rophages, suggesting that a decrease in AAM polarization in the
Stat6/ mice contributes to their increased resistance to
B. abortus infection (Figure 3E).
PPARg Promotes Intracellular B. abortus Replication
in AAMs
A pathway that is crucial to acquisition and maintenance of the
AAM phenotype is mediated by PPARs, a family of nuclear re-
ceptors that regulate transcription of genes involved in cellular
metabolism (Odegaard et al., 2007; Vats et al., 2006). Since
our previous studies of B. abortus genes involved in persistent
but not acute infection implicated metabolic genes in this pro-
cess (Hong et al., 2000), we tested the hypothesis that PPAR-
mediated changes to macrophage metabolism could provide
an environment for intracellular persistence of B. abortus. To
determine whether any of the PPARs could be involved in this
process, we analyzed transcripts of the PPARs in splenic
CD11b+ cells. Our results showed that transcription of Pparg,
the gene encoding PPARg, was reduced during acute infection
compared to uninfected controls, while during chronic infection
(30–60 days) it was elevated (Figure 4A). Moreover, Ifng/
mice had increased Pparg expression in splenic macrophages
during acute infection, while the opposite was true for chronically
infected Stat6/ mice when compared to control animals (data
not shown). In B. abortus-infected mice, blocking of PPARg
activity by treating the mice with the inhibitor GW9662 specif-
ically prior to chronic infection (days 18–30) led to a significant
decrease in splenic colonization at 30 days after infection, sug-
gesting that pathways downstream of PPARg contribute to
generating a niche for persistence of B. abortus (Figure 4B).
Concomitantly, PPARg inhibition led to a reduction in the propor-
tion of Ly6Clow CD301+ AAMs in the spleen at 30 dpi (Figure 4C),
as well as to decreased expression of the AAMmarker Ym1 and
to increased expression levels of CAM gene Nos2 and in splenic
CD11b+ cells (Figure S3A). These results suggested that inhibi-
tion of PPARg reduced B. abortus survival by reducing the abun-
dance of AAMs during chronic infection (Figure 4C).
Conversely, treatment of B. abortus-infected mice with the
PPARg agonist Rosiglitazone led to a small (2-fold) increase in
B. abortus colonization during the acute (9 day) phase and an
4-fold increase during the chronic (30 day) infection phase
(Figure 4D). During the acute infection phase, Rosiglitazone
treatment led to an increased percentage of Ly6ClowCD301+
macrophages (Figure 4E), as well as a shift toward expressionCell Hosof AAM markers and a reduction in the CAM marker Nos2 (Fig-
ure S3B), suggesting that the increase in B. abortus infection in
Rosiglitazone-treated mice resulted from a relative increase in
AAMs during the acute phase of infection. Since systemic mod-
ulation of PPARg activity could have effects on cells other than
macrophages, we repeated these treatments on in vitro polar-
ized AAMs. Similar to what we observed in vivo, Pparg was
strongly induced in AAMs differentiated in vitro (Figure 4F).
Inhibition of PPARg activity in AAMs with GW9662 resulted
in a decreased ability to support intracellular replication of
B. abortus, while activation of PPARg led to an additional
increase in B. abortus replication (Figure 4G). Moreover, fluores-
cence microscopy analysis confirmed that increased B. abortus
CFU counts in AAMs and PPARg-stimulated macrophages
were due to increased bacterial numbers within each cell, rather
than a higher number of infected cells (Figure S3C). Together,
these results suggest that PPARg-dependent modulation of
macrophage physiology promotes intracellular persistence of
B. abortus.
PPARg Increases the Availability of Intracellular
Glucose in AAMs
One of themetabolic changesmediated by PPARg is a shift from
oxidative metabolism of glucose to b-oxidation of fatty acids.
Further, PPARg agonists are used therapeutically to lower blood
glucose by increasing cellular glucose uptake (Yki-Ja¨rvinen,
2004). Since B. abortus is able to utilize glucose for growth
(McCullough and Beal, 1951), we tested the possibility that
increased intracellular glucose availability could promote intra-
cellular replication of B. abortus in AAMs.
We first investigated whether B. abortus infection altered the
phenotype of macrophages cultured in vitro. Infection of nonpo-
larized macrophages with B. abortus or the closely related
B. melitensis led to moderately increased abundance of glyco-
lytic pathway enzymes (Figure S4A), as well as an increase in
expression of the CAM markers Hifa, Pfkfb3, and Glut1 (Figure
S4B). In contrast, B. abortus infection decreased expression of
Pgc1b, encoding a transcriptional activator and of Acadm and
Acadl, encoding enzymes involved in mitochondrial b-oxidation
(Figure S4C). The induction of the glycolytic pathway in
B. abortus-infected macrophages was confirmed by detection
of increased concentrations of extracellular lactate, an end prod-
uct of glycolysis (Figure S4D). The relative induction of the
macrophage glycolytic pathway by B. abortus was dependent
on the macrophage phenotype: infection of CAMs (induced by
IFNg) or AAMs (induced by IL-4) treated with the PPARg antag-
onist GW9662 shifted the metabolism more strongly toward
glycolysis and led to a marked reduction in b-oxidation genes
expression (Figures 5A–5C). In contrast, compared to control
(untreated) macrophages, the shift toward glycolysis induced
byB. abortus infection was attenuated in AAMs or in cells treated
with Rosiglitazone (Figures 5A–5C). Taken together, these data
suggested that while B. abortus infection does not induce AAM
polarization, infection of AAMs results in lower induction of the
glycolytic pathway in the infected macrophages.
Compared to untreated control BMDMs, AAMs induced
in vitro by IL-4 treatment had significantly elevated glucose con-
tent, which was lowered to the level of control macrophages by
infection with B. abortus, raising the possibility that the pathogent & Microbe 14, 159–170, August 14, 2013 ª2013 Elsevier Inc. 163
Figure 4. Increased Survival of B. abortus during Chronic Infection Is Dependent on PPARg
(A) Real-time RT-PCR gene expression analysis of Pparg in CD11b+ splenocytes from B. abortus-infected C57BL/6J mice (n = 5) at 3, 9, 30, and 60 dpi.
(B)B. abortus 2308CFU counts,measured at 30 dpi, in spleens fromC57BL/6Jmice (n = 5) treated daily from 18 to 30 dpi with PPARg antagonist GW9662 or PBS
control.
(C) Frequency of CD3B220NK1.1Ly6GCD11b+F4/80+Ly6ClowCD301+ macrophages (AAM) measured by flow cytometry at 30 dpi in spleens of C57BL/6J
mice (n = 5) treated daily from 18 to 30 dpi with PPARg antagonist GW9662 or PBS control.
(D) B. abortus 2308 CFU counts, measured at 9 and 30 dpi, in spleens from C57BL/6J mice (n = 5) treated daily for 7 days prior to infection with PPARg agonist
Rosiglitazone or PBS control.
(E) Frequency of CD3B220NK1.1Ly6GCD11b+F4/80+Ly6ClowCD301+ macrophages (AAM) measured by flow cytometry at 9 and 30 dpi in spleens from
C57BL/6J mice (n = 5) treated daily for 7 days prior to infection with PPARg agonist Rosiglitazone or PBS control.
(F) Real-time RT-PCR gene expression analysis of Pparg in BMDMs fromC57BL/6Jmice stimulated with rIFN-g (CAM) or rIL-4 (AAM), or nonstimulated (Control),
and infected with B. abortus for 24 hr. Data shown are compiled from four independent experiments.
(G) B. abortus 2308 CFU counts in BMDMs from C57BL/6J mice, stimulated with rIL-4 (AAM) or with IL-4 + 3 mMof PPARg antagonist GW9662 (GW9662) or with
5 mM of PPARg agonist Rosiglitazone and infected with B. abortus for 24 and 48 hr. Data shown in (F) and (G) are compiled from four independent experiments.
Values represent mean ± SEM. *p < 0.05 using one way ANOVA for (A) and (F) or unpaired t test analysis for (B)–(E) and (G). See also Figure S3.
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lular glucose in AAMs was recapitulated by treatment with Rosi-
glitazone, and was negated by treatment of AAMs with GW9662,
suggesting that increased intracellular glucose in AAMs is
dependent on PPARg-mediated transcriptional changes (Fig-
ure 5D). Interestingly, our previous work identified a glucose
transporter of the major facilitator superfamily, GluP, as a
B. abortus factor required for chronic, but not acute, infection
(Essenberg et al., 1997; Hong et al., 2000).
To directly test the idea that glucose availability could promote
intracellular replication of B. abortus in AAMs, we compared
replication of wild-type B. abortus and the gluP mutant.
In vitro, the gluP mutant grew similarly to wild-type B. abortus
in medium (Tryptone/Soytone) lacking glucose, while addition
of glucose enhanced replication of wild-type B. abortus, but164 Cell Host & Microbe 14, 159–170, August 14, 2013 ª2013 Elsevinot of the gluP mutant (Figure S5A). Enhanced growth in
glucose-containing medium was restored by complementation
of the gluP mutation (Figure S5A). Remarkably, while there was
no difference in the ability of the two B. abortus strains to survive
in untreated control macrophages, wild-type B. abortus was
recovered in 10-fold greater numbers than the gluP mutant
from AAMs (Figure 6A). Treatment of unpolarized BMDM with
Rosiglitazone increased the intracellular replication of wild-type
B. abortus but had no effect on intracellular replication of the
gluP mutant, consistent with an inability to utilize increased
glucose within the macrophage (Figure 6B). The growth advan-
tage of wild-type B. abortus over the gluPmutant was eliminated
by treatment of AAMs with GW9662 (Figure 6B). Inhibition of
mitochondrial b-oxidation in AAMs or Rosiglitazone-treated
cells, using the carnitine palmitoyltransferase inhibitor etomoxir,er Inc.
Figure 5. B. abortus-Infected AAMs Exhibit a PPARg-Dependent Decrease in Glycolytic Metabolism
(A) Real-time RT-PCR gene expression analysis of glycolytic pathway genesHifa (hypoxia-inducible factor a),Pfkfb3 (phosphofructokinase-3), andGlut1 (glucose
transporter 1) in C57BL/6J BMDM stimulated with rIFNg (CAM), with rIL-4 (AAM), with IL-4 + GW9662 (GW9662), or with Rosiglitazone and infected with
B. abortus for 8 hr. Results are expressed as fold change over untreated macrophages infected with B. abortus.
(B) Real-time RT-PCR gene expression analysis of fatty acid b-oxidation pathway genes Pgc1b (PPARg coactivator 1 b), Acadm (medium-chain acyl-CoA
dehydrogenase), and Acadl (long-chain acyl-CoA dehydrogenase) in BMDMs from C57BL/6J stimulated rIFNg (CAM), with rIL-4 (AAM), with IL-4 + GW9662
(GW9662), or with Rosiglitazone and infected withB. abortus for 8 hr. Results are expressed as fold change over untreatedmacrophages infectedwithB. abortus.
(C) Measurement of lactate concentration in supernatant from BMDM from C57BL/6J stimulated with rIFNg (CAM), with rIL-4 (AAM) or IL-4 + GW9662 (GW9662),
or with Rosiglitazone and uninfected or infected with B. abortus for 24 hr.
(D) Measurement of intracellular glucose concentration in BMDMs from C57BL/6J unstimulated (control) and stimulated with rIL-4 (AAM), with IL-4 + GW9662
(GW9662), or with Rosiglitazone and uninfected or infected with B. abortus for 24 hr. Values represent mean ± SEM and represent combined results of four
independent experiments conducted in duplicate. *p < 0.05 and **p < 0.01 using one-way ANOVA. See also Figure S4.
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but had no effect on the gluPmutant (Figure 6C and Figure S5B).
The growth defect of the gluP mutant within AAMs or Rosiglita-
zone-treated macrophages was restored by complementation
(Figures 6D and 6E), demonstrating that the ability to transport
glucose is essential for increased growth in these macrophages.
To control for possible off-target effects of the inhibitors on
B. abortus, we examined replication of wild-type and the gluP
mutant in macrophages from conditionally PPARg-deficient
mice, in which only macrophages lack PPARg (Figures S5C
and S5D). Similarly to what was observed with the PPARg
inhibitor-treated AAMs (Figure 6B), GluP-dependent replication
of B. abortus within either IL-4 or Rosiglitazone-treated macro-
phages was dependent on the function of PPARg (Figures S5C
and S5D). These results provide evidence that the increased
replication of B. abortus in AAMs is dependent on its ability to
utilize the elevated intracellular pool of glucose that is induced
by PPARg.Cell HosPersistent Infection byB. abortusDepends on the Ability
to Transport Glucose
The results presented above raised the question of whether the
PPARg-dependent increase in glucose concentration that we
observed in cultured macrophages could also promote
B. abortus infection in vivo. To investigate this, we determined
the requirement for GluP during acute and chronic infection (Fig-
ure 7A), using a competitive infection assay. During acute infec-
tion (9 days), the ratio of wild-type B. abortus to the gluPmutant
was not significantly different from the 1:1 ratio in the inoculum
(Figure 7A). However, during chronic infection, the gluP mutant
was outcompeted 20-fold by the wild-type. To determine
whether this competitive defect was the result of PPARg activa-
tion, we repeated the experiment in mice treated with the PPARg
antagonist GW9662 (Figure 7B). Inhibition of PPARg during the
chronic infection stage strongly reduced the competitive defect
of the gluPmutant at 30 dpi. Since the survival defect of the gluP
mutant was observed only during chronic infection, whenPPARgt & Microbe 14, 159–170, August 14, 2013 ª2013 Elsevier Inc. 165
Figure 6. A PPARg-Dependent Increase in Intracellular Glucose Availability Promotes Survival of B. abortus in Macrophages
(A) Recovery of B. abortus from C57BL/6J BMDM that were sham treated (Control) or treated with rIL-4 (AAM). BMDM were infected with B. abortus 2308 WT or
isogenic gluP mutant for 8, 24, and 48 hr.
(B) Recovery of B. abortus from C57BL/6J BMDM stimulated with rIL-4 (AAM), with IL-4 + GW9662 (GW9662), or with Rosiglitazone (Rosi) and infected with
B. abortus 2308 (WT) or isogenic gluP mutant for 24 and 48 hr.
(C) Recovery of B. abortus from BMDMs from C57BL/6J treated or not with the b-oxidation inhibitor etomoxir (50 mM) in the presence of rIL-4 (AAM) or
Rosiglitazone and infected with B. abortus 2308 WT or isogenic gluP mutant for 48 hr.
(D) Recovery of B. abortus from BMDMs from C57BL/6J stimulated rIL-4 (AAM) and infected with B. abortus 2308 WT or isogenic gluPmutant or complemented
gluP mutant (gluP::pGLUP1) for 8, 24, and 48 hr.
(E) Recovery of B. abortus from BMDMs from C57BL/6J stimulated with Rosiglitazone and infected with B. abortus 2308 WT or isogenic gluP mutant or com-
plemented gluP mutant (gluP::pGLUP1) for 8, 24, and 48 hr. Values represent mean ± SEM of data from four independent experiments conducted in duplicate.
*p < 0.05 using unpaired t test for (A)–(C) or one-way ANOVA statistical analysis for (D) and (E). See also Figure S5.
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PPARg during acute infection would affect the survival of the
gluP mutant (Figure 7C). Treatment of mice during acute infec-
tion with Rosiglitazone increased the ability of the wild-type
B. abortus to outcompete the gluP mutant at 9d by approxi-
mately 4-fold, resembling the phenotype only previously seen
at later stages of infection (30 days). Finally, to control for off-
target effects of the inhibitors, we repeated the competitive
infection in mice conditionally deficient for Pparg expression in
macrophages (Ppargflox/flox LysMcre/; Odegaard et al., 2007).
The growth advantage of wild-type B. abortus over the gluP
mutant was strongly reduced in the conditionally Pparg-deficient
mice (Figure 7D), demonstrating that expression of PPARg
specifically in macrophages is required for B. abortus to benefit
from acquisition of glucose in AAMs during chronic infection.
Taken together, these results demonstrate that, in vivo, the abil-
ity of B. abortus to benefit from PPARg-mediated changes in166 Cell Host & Microbe 14, 159–170, August 14, 2013 ª2013 Elsevihost macrophage metabolism is dependent on the ability of
B. abortus to take up glucose.
DISCUSSION
Recent studies have shed light on the extensive interactions
between immune and metabolic functions of macrophages.
For the case of CAMs, oxygen is required as a substrate for
NADPH oxidase, and therefore these cells meet their energetic
needs via anaerobic glycolysis. Since anaerobic glucose utiliza-
tion is a relatively inefficient way to generate ATP (only 2 ATP/
molecule of glucose), a large amount of glucosemust be utilized,
and the relative intracellular concentration of free glucose is low.
In contrast, in AAMs, this metabolic program is antagonized by
STAT6-dependent induction of PPARg and PPARd (Szanto
et al., 2010). As a result, AAMs shift to aerobic metabolism, in
which they gain energy by b-oxidation of fatty acids (Bensingerer Inc.
Figure 7. A PPARg-Dependent Increase in
Intracellular Glucose Availability in Macro-
phages Promotes B. abortus Persistence
In Vivo
(A) Competitive index (ratio of WT to gluP mutant)
in spleens of C57BL/6J mice (n = 5) infected with a
1:1 mixture of B. abortus 2308 WT and isogenic
gluP mutant for 9 and 30 days.
(B) Competitive index, measured at 30 days
postinfection (dpi), in spleens from C57BL/6J mice
(n = 5) treated daily from 18 to 30 dpi with PPARg
antagonist GW9662 or PBS control and infected
with a 1:1 mixture of B. abortus 2308 WT and
isogenic gluP mutant.
(C) Competitive index, measured at 9 and 30 dpi, in
spleens from C57BL/6J mice (n = 5) treated daily
for 7 days prior to infection with PPARg agonist
Rosiglitazone or PBS control and infected with a
1:1 mixture of B. abortus 2308 WT and isogenic
gluP mutant.
(D) Competitive index, measured at 9 and 30 dpi, in
spleens from Ppargfl/flLysMcre/- (Mac-PPARg KO)
or littermates Ppargfl/flLysM/ (Control) mice
(n = 5) infected with a 1:1 mixture of B. abortus
2308 WT and isogenic gluP mutant. Values
represent mean ± SEM. *p < 0.05 using unpaired
t test statistical analysis.
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demonstrate that this metabolic shift leads to an increase in
intracellular glucose, which becomes available to support
growth of intracellular bacteria (Figure 5). An exhaustive screen
of B. suis genes required for intracellular infection in human
THP-1 cells identified sugar metabolism genes as being required
for intracellular infection and suggested that the replicative niche
forBrucellawithin the cell is poor in nutrients (Kohler et al., 2002).
Further, at late stages during cellular infection, the bacterial
glycolysis pathway was downregulated, which led to the propo-
sition thatBrucellamay use fatty acids or amino acids rather than
sugars during this growth phase (Al Dahouk et al., 2008; Barbier
et al., 2011). However, the increased growth rate of B. abortus
within AAMs in vitro compared to unpolarized or CAM-polarized
macrophage populations used for previous studies suggests
that AAMs may provide additional nutrients, such as glucose,
that are less abundant in other macrophage populations.
Like B. abortus, other bacteria have been shown to induce
PPARg expression, such asMycobacterium tuberculosis (Maha-
jan et al., 2012) and Listeria monocytogenes (Abdullah et al.,
2012). Interestingly, a lack of PPARg expression inmacrophages
was shown to render mice more resistant to L. monocytogenes
infection (Abdullah et al., 2012). While the underlying mechanism
in this studywas not identified, our work shows that antagonizing
PPARg activity during B. abortus infection helps control the
pathogen burden by reducing intracellular glucose availability.
Importantly, these observations, together with findings by Eisele
et al. (2013; in this issue) demonstrating that PPARd-dependent
modulation of glucose concentration stimulates intracellular
growth of Salmonella enterica serotype Typhimurium in AAM,Cell Hosraise the possibility that PPAR-induced increases in intracellular
glucose availability may be a general mechanism promoting
growth of persistent pathogens within AAMs.
It should be noted that unlike Francisella tularensis, which
induces differentiation of AAMs to promote its replication (Shirey
et al., 2008), B. abortus does not appear to induce this pathway
directly, since cultivation ofB. abortuswith BMDM in vitro did not
induce expression of AAM markers (Figure S4). Rather, as a
result of its inherently low TLR4-stimulatory activity for macro-
phages and dendritic cells (reviewed by Martirosyan et al.,
2011), B. abortus induces only a weak and transient Th1
response during the acute infection phase, which is character-
ized by an influx of inflammatory macrophages (Figure 1, Fig-
ure S2A; and Copin et al., 2012). It is likely that this transient
IFNg response is unable to sustain the CAM polarization of
these cells, and perhaps together with the constant IL-4 levels
throughout infection (Figure S2B) as well as induction of
IL-13 (Figure S2C) and PPARg during chronic infection by
B. abortus, macrophages that have already entered the site of
infection may become polarized to the AAM phenotype. Such
a scenario would be consistent with our finding of similar
increases in macrophage numbers during both acute and
chronic infection but a relative increase in AAMs only during
the chronic infection phase. These findings in the mouse model
are consistent with reports of transient IFNg responses and an
increase in IL-13 producing T cells in human patients with
chronic brucellosis (Rafiei et al., 2006).
Our results fit with previous reports suggesting that, during
chronic infection, persistent pathogens undergo a shift in
their metabolism. For example, it has long been known thatt & Microbe 14, 159–170, August 14, 2013 ª2013 Elsevier Inc. 167
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infection (Wayne and Lin, 1982), and characterization of isoci-
trate lyase, an enzyme of this pathway needed for the chronic,
but not the acute phase of infection (McKinney et al., 2000), iden-
tified this enzyme as a potential therapeutic target. Like tubercu-
losis, brucellosis is a chronic infection causing significant
morbidity that requires protracted treatment with multiple antibi-
otics. Treatment failures and relapses are common for brucel-
losis; therefore identification of PPARg, a well-characterized
drug target, as a host factor providing a metabolic advantage
to B. abortus during chronic infection suggests inhibitors of
PPARg as a potential adjunct to antibiotic therapy for the preven-
tion of relapsing chronic infection.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Media, and Culture Conditions
Bacterial strains used in this study were the virulent strain Brucella abortus
2308; its isogenic mutant strain MX2, which has an insertion of pKSoriT-bla-
kan-PsojA-mCherry plasmid (Copin et al., 2012); BA159 (gluP), which has a
miniTn5 Km2 transposon insertion interrupting the gluP locus (Hong et al.,
2000); and the complemented gluP mutant MX6 (gluP::pGLUP1). For con-
struction of strain MX6, the gluP gene sequence including its promoter was
amplified by PCR using the primers GluP FWD, 50- GTCGACTTTGTTGGCTTT
CAAGTGG-30; and GluP REV, 50-GGATCCTCGCCATTCTATTCGGTTTC-30.
The resulting gluP PCR product was cloned into pCR2.1 using the TOPO TA
cloning kit (Invitrogen, Carlsbad) and correct insertion confirmed by
sequencing (SeqWright Fisher Scientific, Houston) and plasmid digestion
using enzymes SalI and BamHI. The final construct (pGLUP1) was introduced
by electroporation to strain BA159 to reconstitute the intact gene. For strain
MX6, positive clones were selected based on ampicillin (Amp) resistance,
and intact gene chromosomal insertion was further confirmed by PCR. For
strain MX2, positive clones were kanamycin (Km) resistant and fluorescent,
as previously described (Copin et al., 2012). Strains were cultured on tryptic
soy agar (Difco/Becton Dickinson, Sparks, MD) or tryptic soy broth at 37C
on a rotary shaker. Bacterial inocula for mouse infection were cultured on
tryptic soy agar plus 5% blood for 3 days (Alton et al., 1975). For cultures of
strain MX2 and BA159, Km was added to the culture medium at 100 mg/mL.
All work with B. abortus cells was performed at biosafety level 3 and
was approved by the Institutional Biosafety Committee at the University of
California, Davis.
Animal Experiments
Female C57BL/6J wild-type mice, Ifng/ mice, Ccr2/ mice, and Stat6/
mice, aged 6–8 weeks, were obtained from The Jackson Laboratory (Bar
Harbor). Female and male C57BL/6 Ppargfl/flLysMcre/- (Mac-PPARg KO) and
littermate Ppargfl/flLysM/ (control) mice were generated at UC Davis by mat-
ing Ppargfl/flmice with LysMcre/cre mice (The Jackson Laboratory, Bar Harbor).
Mice were held in microisolator cages with sterile bedding and irradiated feed
in a biosafety level 3 laboratory. Groups of four to six mice were inoculated
intraperitoneally (i.p.) with 0.2 ml of phosphate-buffered saline (PBS) contain-
ing 53 105CFU ofB. abortus 2308 or a 1:1mixture ofB. abortus 2308 and gluP
mutant as previously described (Rola´n and Tsolis, 2008). At 0, 3, 9, 15, 21, 30,
and/or 60 days after infection, according to the experiment performed, the
mice were euthanized by CO2, and their spleens were collected aseptically
at necropsy. The spleens were homogenized in 2 ml of PBS, and serial dilu-
tions of the homogenate were plated on TSA and/or TSA+ kanamycin for
enumeration of CFU. Spleen samples were also collected for gene expression,
flow cytometry, and immunohistochemistry analysis as described below. All
animal experiments were approved by the University of California Laboratory
Animal Care and Use Committee and were conducted in accordance with
institutional guidelines.
Bone Marrow-Derived Macrophage Infection
BMDMs were differentiated from bone marrow precursors from femora and
tibiae of female, 6- to 8-week-old, C57BL/6J mice or Mac-PPARg KO168 Cell Host & Microbe 14, 159–170, August 14, 2013 ª2013 Elsevi(Pparg/) and littermate control (WT) mice following a previously published
procedure (Rola´n and Tsolis, 2007). For BMDM experiments, 24-well microti-
ter plates were seeded with macrophages at concentration of 5 3 105 cells/
well in 0.5 ml of RPMI media (Invitrogen, Grand Island, NY) supplemented
with 10% FBS and 10 mM L-glutamine (RPMI supl) incubated for 48 hr at
37C in 5% CO2. Preparation of the inoculum and BMDM infection was per-
formed as previously described (Rola´n and Tsolis, 2007). Briefly, for inoculum
preparation, B. abortus 2308 or B. abortus BA159 (gluP) or MX6 was grown for
24 hr and then diluted in RPMI supl, and about 5 3 107 bacteria in 0.5 ml of
RPMI supl was added to each well of BMDM, reaching multiplicity of infection
(moi) of 100. Microtiter plates were centrifuged at 210 3 g for 5 min at room
temperature in order to synchronize infection. Cells were incubated for
20 min at 37C in 5% CO2, free bacteria were removed by three washes
with phosphate-buffered saline (PBS), and the zero time point sample was
taken as described below. After the PBS wash, RMPI supl plus 50 mg genta-
micin per mL was added to the wells, and the cells were incubated at 37C in
5% CO2. In order to determine bacterial survival, the medium was aspirated
at 0, 8, 24, and 48 hr after infection according to the experiment performed,
and the BMDMs were lysed with 0.5 ml of 0.5% Tween 20, followed by rising
of each well with 0.5 ml of PBS. Viable bacteria were quantified by serial dilu-
tion in sterile PBS and plating on TSA. For gene expression assays, BMDMs
were resuspended in 0.5 ml of TRI-reagent (Molecular Research Center, Cin-
cinnati) at the time points described above and kept at80C until further use.
When necessary, 10 ng/mL of mouse rIFN-g (BD Bioscience, San Jose, CA),
10 ng/mL of mouse rIL-4 (BD Bioscience, San Jose, CA), 3 mM of GW9662
(Cayman Ann Harbor, MI), 5 mM of Rosiglitazone (Cayman, Ann Harbor, MI),
or 50 mM of Etomoxir (Sigma-Aldrich, St Louis, MO) was added to the wells
overnight prior to experiment and kept throughout the experiments. All exper-
iments were performed independently in duplicate at least four times and the
standard error for each time point calculated.
CD11b+ Cell Isolation
Macrophages (CD11b+ cells) were isolated from the spleens of B. abortus-
infected C57BL/6J, congenic Ccr2/, Ifng/, and Stat6/ mice with a
MACS CD11b MicroBeads magnetic cell sorting kit from Miltenyi Biotech
(Auburn, CA) by following the manufacturer’s instructions, as previously
described (Rola´n et al., 2009). Briefly, single-cell suspension was prepared
by gently teasing apart the spleens, followed by passage of splenocytes
through a 70 mm cell strainer and treatment with ACK buffer (Lonza, Walkers-
ville, MD) to lyse red blood cells. Cells were washed with PBS-BSA, counted,
and incubated with CD11b MicroBeads. Cells were applied to a magnetic
column, washed, eluted, and counted. For gene expression assays, total
splenic CD11b+ cells per mouse were resuspended in 0.5 ml of TRI reagent
(Molecular Research Center, Cincinnati) and kept at 80C until further use.
For B. abortus recovery essay, viable bacteria in CD11b and CD11b+ spleno-
cytes fractions was determined by 10-fold serial dilution in sterile PBS and
plating on TSA. The results were normalized to CFU per 106 cells.
Treatment with PPARg Agonist/Antagonist In Vivo
Female C57BL/6Jmice were inoculated intraperitoneally (i.p.), daily, for 7 days
prior to B. abortus infection, with 5 mg/kg/day of the PPARg agonist Rosiglita-
zone (Cayman, Ann Harbor, MI) diluted in 0.2 ml of sterile PBS solution. For the
treatment with PPARg antagonist GW9662 (Cayman, Ann Arbor, MI), female
C57BL/6J mice were inoculated intraperitoneally (i.p.), daily, from day 18 till
day 30 post-B. abortus infection, with 3 mg/kg/day of PPARg antagonist
GW9662 (Cayman, Ann Arbor, MI) diluted in 0.2 ml of sterile PBS solution.
RT-PCR and Real-Time PCR Analysis
Eukaryotic gene expression was determined by real-time PCR as previously
described (Rola´n and Tsolis, 2007). Briefly, eukaryotic RNA was isolated using
TRI reagent (Molecular Research Center, Cincinnati) according to the manu-
facturer’s instructions. A reverse transcriptase reaction was performed to
prepare complementary DNA (cDNA) using TaqMan reverse transcription
reagents (Applied Biosystems, Carlsbad CA). A volume of 4 ml of cDNA was
used as template for each real-time PCR reaction in a total reaction volume
of 25 mL. Real-time PCR was performed using SYBR Green (Applied Bio-
systems) along with the primers listed in Table S1. Data were analyzed using
the comparative Ct method (Applied Biosystems). Transcript levels of IL-6,er Inc.
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were normalized to mRNA levels of the housekeeping gene act2b, encoding
b-actin.
Flow Cytometry
Flow cytometry analysis for detection of CAMs, AAMs, and/or B. abortus intra-
cellular localization was performed in splenocytes and/or CD11b+ splenic cells
of C57BL/6J mice infected with B. abortus 2308 for 9 or 30 days. Briefly, after
passing the spleen cells through a 100 mm cell strainer and treating the sam-
ples with ACK buffer (Lonza, Walkersville, MD) to lyse red blood cells, spleno-
cytes were washed with PBS (GIBCO) containing 1% bovine serum albumin
(fluorescence-activated cell sorter [FACS] buffer). After cell counting, 4 3
106 cells/mouse were resuspended in PBS and stained with Aqua Live/Dead
cell discriminator (Invitrogen, Grand Island, NY) according to the manufac-
turer’s protocol. After Live/Dead staining, splenocytes were resuspended in
50 ml of FACS buffer, and cells were stained with cocktail of anti-B220 PE
(BD Pharmigen, San Jose, CA), anti-CD3 PE (BD PharMingen), anti-NK1.1
PE (BD Pharmigen), anti-CD11b FITC (BD PharMingen), anti-F4/80 Pe.Cy7
(Biolegend, San Diego, CA), anti-Ly6C Pacific Blue (Biolegend), anti-Ly6G
PerCP Cy5.5 (Biolegend), and anti-CD301 AF647 (AbD serotec, Raleigh,
NC). The cells were washed with FACS buffer and fixed with 4% formaldehyde
for 30 min at 4C. To determine intracellular B. abortus localization in CD11b+
splenocytes, cells were stained with cocktail of anti-CD11c PE (BD
PharMingen), anti-CD11b FITC (BD PharMingen), anti-F4/80 Pe.Cy7
(Biolegend), anti-Ly6C Pacific Blue (Biolegend), anti-Ly6G PerCP Cy5.5
(Biolegend), and anti-CD301 AF647 (AbD Serotec), followed by cell fixation
and permeabilization using Cytofix/Cytoperm (BD Pharmigen) at 4C for
30 min. For intracellular B. abortus labeling, Cd11b+ splenocytes were ressus-
pended in 50 mL of Perm/Wash buffer (BD Pharmigen) and stained with
APC.Cy7 (AbD Serotec) conjugated goat anti-B. abortus antibody followed
by two washes with Perm/Wash buffer. For all experiments, cells were ressus-
pended in FACS buffer prior to analysis. Flow cytometry analysis was per-
formed using an LSRII apparatus (Becton Dickinson, San Diego, CA), and
data were collected for 5 3 105 cells/mouse. Resulting data were analyzed
using Flowjo software (Treestar, inc. Ashland, OR). Gates were based on Fluo-
rescence-Minus-One (FMO) controls.
Lactate Measurement
For determination of extracellular lactate levels, C57BL/6J BMDMwere grown
in 24-well plates using RPMI media (Invitrogen, Grand Island, NY) supple-
mented with 2% FBS and 10 mM L-glutamine (RPMI supl) and infected as
described above. At 24 hr postinfection, supernatants were collected, and
lactate measurement was performed by using a Lactate Colorimetry Assay
Kit (Biovision, Milpitas, CA) according to the manufacturer’s instructions.
Glucose Measurement
For determination of intracellular glucose levels, C57BL/6J BMDMs were
grown in 24-well plates and infected as described above. At 24 hr postinfec-
tion, cells were washed three times with cold PBS and resuspended in
100 ml of glucose assay buffer. Further glucose measurement was performed
by using a Glucose Assay Kit (Biovision) according to the manufacturer’s
instructions.
Statistical Analysis
Fold changes of ratios (bacterial numbers or mRNA levels) and percentages
(flow cytometry and fluorescence microscopy) were transformed logarithmi-
cally prior to statistical analysis. An unpaired Student’s t test was used on
the transformed data to determine whether differences between groups
were statistically significant (p < 0.05). When more than two treatments were
used, statistically significant differences between groups were determined
by one-way ANOVA. All statistical analysis was performed using GraphPad
Prism version 6b software (GraphPad Software, La Jolla, CA).
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